Literature DB >> 23028054

IL-1 family members IL-18 and IL-33 upregulate the inflammatory potential of differentiated human Th1 and Th2 cultures.

Lars Blom1, Lars K Poulsen.   

Abstract

The IL-1 family members IL-1β, IL-18, and IL-33 are potent cytokines in relationship to amplifying the CD4(+) T cell cytokine production. To evaluate their impact on in vitro-differentiated human Th1 and Th2 cultures, such cultures were established from naive T cells, purified from healthy blood donors, and reactivated in the presence of IL-1β, IL-18, or IL-33. Interestingly, we observe modifying responses in Th1 and Th2 cultures induced by IL-18 or IL-33 but not by IL-1β, both contributing to amplify production of IL-5, IL-13, and IFN-γ. IL-18 or IL-33 stimulation of Th1 cultures resulted in increased IFN-γ and IL-13 production concurrent with reduced IL-10 gene transcription and secretion even though Th1 cultures, in contrast to IL-18Rα, had low ST2L expression. Furthermore, adding IL-18 to Th1 cultures promoted Tbet mRNA expression and production. Th2 cultures stimulated with IL-18 or IL-33 had an increased IL-5 secretion. Interestingly, E4BP4 gene expression and the percentage of E4BP4(+) cells of the recently shown IL-10 transcriptional regulator E4BP4 correlated with IL-10 gene expression and protein secretion in Th1 cultures. Taken together, we report that the IL-1 family "alarmins" IL-18 and IL-33 in addition to amplifying both Th1- and Th2-associated cytokines block production of the regulatory cytokine IL-10 in Th1 cultures.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23028054     DOI: 10.4049/jimmunol.1103685

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  25 in total

1.  Alkylating agent melphalan augments the efficacy of adoptive immunotherapy using tumor-specific CD4+ T cells.

Authors:  Xiaoyun Lu; Zhi-Chun Ding; Yang Cao; Chufeng Liu; Tsadik Habtetsion; Miao Yu; Henrique Lemos; Huda Salman; Hongyan Xu; Andrew L Mellor; Gang Zhou
Journal:  J Immunol       Date:  2015-01-05       Impact factor: 5.422

2.  Combined detections of interleukin-33 and adenosine deaminase for diagnosis of tuberculous pleural effusion.

Authors:  Diandian Li; Yongchun Shen; Xiaomin Fu; Min Li; Tao Wang; Fuqiang Wen
Journal:  Int J Clin Exp Pathol       Date:  2015-01-01

Review 3.  Innate Control of Adaptive Immunity: Beyond the Three-Signal Paradigm.

Authors:  Aakanksha Jain; Chandrashekhar Pasare
Journal:  J Immunol       Date:  2017-05-15       Impact factor: 5.422

4.  The IL-33/ST2 axis augments effector T-cell responses during acute GVHD.

Authors:  Dawn K Reichenbach; Vincent Schwarze; Benjamin M Matta; Victor Tkachev; Elisabeth Lieberknecht; Quan Liu; Brent H Koehn; Dietmar Pfeifer; Patricia A Taylor; Gabriele Prinz; Heide Dierbach; Natalie Stickel; Yvonne Beck; Max Warncke; Tobias Junt; Annette Schmitt-Graeff; Susumu Nakae; Marie Follo; Tobias Wertheimer; Lukas Schwab; Jason Devlin; Simon C Watkins; Justus Duyster; James L M Ferrara; Heth R Turnquist; Robert Zeiser; Bruce R Blazar
Journal:  Blood       Date:  2015-03-26       Impact factor: 22.113

5.  Elevated circulating CD14lowCD16+ monocyte subset in primary biliary cirrhosis correlates with liver injury and promotes Th1 polarization.

Authors:  Anping Peng; Peifeng Ke; Rong Zhao; Xinyi Lu; Cheng Zhang; Xianzhang Huang; Guangjun Tian; Jun Huang; Jinli Wang; Pietro Invernizzi; Qubo Chen; Junhua Zhuang
Journal:  Clin Exp Med       Date:  2015-09-24       Impact factor: 3.984

Review 6.  IL-33 in Tumor Immunity: Nothing to Sneeze At.

Authors:  Donye Dominguez; Yi Zhang; Bin Zhang
Journal:  Crit Rev Immunol       Date:  2018       Impact factor: 2.214

7.  The role of IL-1 family of cytokines and receptors in pathogenesis of COVID-19.

Authors:  Shima Makaremi; Ali Asgarzadeh; Hamed Kianfar; Alireza Mohammadnia; Vahid Asghariazar; Elham Safarzadeh
Journal:  Inflamm Res       Date:  2022-06-25       Impact factor: 6.986

8.  Examining IL-33 expression in the cervix of HPV-infected patients: a preliminary study comparing IL-33 levels in different stages of disease and analyzing its potential association with IFN-γ.

Authors:  Lei Wang; Hongying Li; Feng Liang; Yi Hong; Shaowei Jiang; Ling Xiao
Journal:  Med Oncol       Date:  2014-08-09       Impact factor: 3.064

9.  IL-33 induces nuocytes and modulates liver injury in viral hepatitis.

Authors:  Yuejin Liang; Zuliang Jie; Lifei Hou; Renan Aguilar-Valenzuela; David Vu; Lynn Soong; Jiaren Sun
Journal:  J Immunol       Date:  2013-04-29       Impact factor: 5.422

Review 10.  How Inflammasomes Inform Adaptive Immunity.

Authors:  Charles L Evavold; Jonathan C Kagan
Journal:  J Mol Biol       Date:  2017-10-05       Impact factor: 5.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.